TY - JOUR
T1 - Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation
T2 - The West Birmingham Atrial Fibrillation Project
AU - Li, Yan-Guang
AU - Miyazawa, Kazuo
AU - Pastori, Daniele
AU - Szekely, Orsolya
AU - Shahid, Farhan
AU - Lip, Gregory Y H
N1 - Copyright © 2019 Elsevier B.V. All rights reserved.
PY - 2019/10
Y1 - 2019/10
N2 - Background: Patients with cardiac implantable electronic device (CIED) developing atrial high-rate episodes (AHRE) have a significant risk of thromboembolic events (TEs), but risk factors have been scarcely investigated. Objectives: To analyze risk factors for TEs in a contemporary cohort of patients with CIED. Methods: Consecutive non-AF patients without anticoagulation at baseline were followed up after the CIED implantation. The role of newly-developed AHRE and other risk factors for TEs were analyzed using a time-dependent Cox regression model and Kaplan-Meier analysis with log-rank tests. Results: A total of 594 CIED patients were followed up for a mean of 4.2 years: 175 developed AHRE (29.5%; incident rate [IR] 8.80% per patient-year). Of those, 33 experienced TEs (5.5%; IR 1.38% per patient-year). Incidence of TEs was low in patients with a CHA
2DS
2-VASc score < 2 (male)/<3 (female) (AHRE vs. no-AHRE, 0.60% vs. 0.00% per patient-year, p = 0.469) and high in those with score ≥ 2 (male)/≥3 (female) (AHRE vs. no-AHRE, 2.12% vs. 1.36% per patient-year, p = 0.209), regardless of the AHRE presence. AHRE was not significantly associated with TEs (hazard ratio [HR], 1.46 [0.64–3.33]). There was no temporal relationship between AHRE and TEs. Baseline CHA
2DS
2-VASc score was independently associated with TEs (HR, 1.41 [1.13–1.75]) on multivariate analysis, but not AHRE. Conclusions: Thromboembolic risk in patients with CIED is mainly driven by comorbidity burden, i.e., CHA
2DS
2-VASc score, rather than AHRE per se. Decision-making on stroke prevention needs to focus on comorbidity burden and not merely on the presence or absence of AHRE in CIED patients.
AB - Background: Patients with cardiac implantable electronic device (CIED) developing atrial high-rate episodes (AHRE) have a significant risk of thromboembolic events (TEs), but risk factors have been scarcely investigated. Objectives: To analyze risk factors for TEs in a contemporary cohort of patients with CIED. Methods: Consecutive non-AF patients without anticoagulation at baseline were followed up after the CIED implantation. The role of newly-developed AHRE and other risk factors for TEs were analyzed using a time-dependent Cox regression model and Kaplan-Meier analysis with log-rank tests. Results: A total of 594 CIED patients were followed up for a mean of 4.2 years: 175 developed AHRE (29.5%; incident rate [IR] 8.80% per patient-year). Of those, 33 experienced TEs (5.5%; IR 1.38% per patient-year). Incidence of TEs was low in patients with a CHA
2DS
2-VASc score < 2 (male)/<3 (female) (AHRE vs. no-AHRE, 0.60% vs. 0.00% per patient-year, p = 0.469) and high in those with score ≥ 2 (male)/≥3 (female) (AHRE vs. no-AHRE, 2.12% vs. 1.36% per patient-year, p = 0.209), regardless of the AHRE presence. AHRE was not significantly associated with TEs (hazard ratio [HR], 1.46 [0.64–3.33]). There was no temporal relationship between AHRE and TEs. Baseline CHA
2DS
2-VASc score was independently associated with TEs (HR, 1.41 [1.13–1.75]) on multivariate analysis, but not AHRE. Conclusions: Thromboembolic risk in patients with CIED is mainly driven by comorbidity burden, i.e., CHA
2DS
2-VASc score, rather than AHRE per se. Decision-making on stroke prevention needs to focus on comorbidity burden and not merely on the presence or absence of AHRE in CIED patients.
KW - Atrial high-rate episode
KW - CHA DS -VASc score
KW - Cardiac implantable electronic device
KW - Risk factor
UR - http://www.scopus.com/inward/record.url?scp=85064611465&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2019.04.055
DO - 10.1016/j.ijcard.2019.04.055
M3 - Journal article
C2 - 31031080
SN - 0167-5273
VL - 292
SP - 126
EP - 130
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -